Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg
What Medicare pays for J9259, what providers bill, and how the price varies across 5 states, drawn from CMS 2023 claims data.
J9259 · the short answer
For injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg, Medicare pays about $12.69 while providers bill $44.83 on average, a 3.5× markup, one of the smaller markups in the catalog. State-level Medicare rates range 1% from lowest to highest.
- Medicare pays
- $12.69
- Providers bill
- $44.83
- Markup
- 3.5×
- Markup percentile
- 18th
Medicare amounts are CMS-published; markup = average submitted charge ÷ average Medicare payment.
Price Range Across States
What You Might Pay
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
How we estimate these prices
These estimates are based on the RAND Hospital Price Transparency Study (4th Edition, 2024), which found that commercial insurance prices average 224% of Medicare rates nationally. We apply category-specific ratios: Drugs (Administered) procedures average 2.24x Medicare rates. Cash/self-pay estimates blend typical cash discounts (55% of billed charges) with Medicare-based estimates (150% of allowed amounts). These are statistical estimates, not quotes. Contact your insurer or provider for actual costs.
Where this markup sits nationally
Markup (billed ÷ Medicare) across 8,901 procedures with a meaningful Medicare rate
4 more affordable than 18% of 8,901 procedures
Each bar is a band; taller bars hold more procedures. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Physician & Other Practitioners · 2023
Prices by State
What the Data Says About Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg
Across 5 states with reporting providers, CPT code J9259 (Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg) shows a national average Medicare payment of $12.69 against an average billed charge of $44.83. That gap, a 3.5x markup, or 253% above the Medicare allowed amount, is among the tightest billed-to-paid spreads we track, this code's chargemaster rate tracks unusually close to the Medicare benchmark.
Drugs (Administered) procedures like this one saw 219.2K services billed to Medicare in 2023 by 211 distinct providers, serving 230 unique beneficiaries. State-level variation is significant: Tennessee reports the lowest average payment at $12.61, while Illinois reports the highest at $12.72. At just 1%, this procedure prices remarkably consistently nationwide, GPCI adjustments barely move the needle for this particular code.
Applying RAND 2024 commercial-to-Medicare ratios specific to the Drugs (Administered) category (2.24x), the estimated commercial insurance price lands near $35.68, with self-pay cash discounts commonly bringing the figure closer to $24.28. Within Drugs (Administered), Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg ranks #232 of 530 tracked procedures by national average Medicare payment.
What to do with this
If you may have injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg done, these steps turn the numbers above into a real-world cost estimate.
- Request a Good Faith Estimate from your provider at least 3 business days before a scheduled procedure, under the No Surprises Act it is an enforceable written price.
- Compare injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg costs in your state, Medicare rates vary by locality. Browse states
- Check a hospital’s published cash price, which is often far below the billed charge. Price transparency
- Understand why billed charges run several times the Medicare rate before you negotiate. Read the guide
Figures here are averages and estimates, not a quote. Confirm coverage and out-of-pocket costs with your insurer and provider.
Frequently Asked Questions
How much does Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg cost?
Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg (CPT J9259) is priced fairly consistently nationwide: Medicare pays $12.69 on average, and the $12.61-$12.72 state range stays relatively tight. Providers typically bill $44.83.
Why do providers charge more than Medicare pays?
Providers set their own chargemaster rates (billed charges), which are typically much higher than what any insurer pays. Medicare pays a fixed rate based on the procedure code and geographic location. The billed charge is relevant mainly for uninsured patients, who may face prices closer to the submitted charge.
How much does Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg cost with insurance?
With commercial insurance, injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg costs an estimated $35.68 on average (range: $24.98-$49.96), a moderate premium over Medicare's $12.69. Without insurance, the estimated cash price is $24.28.
Which state has the lowest cost for Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg?
Tennessee and Illinois bookend the range for Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg, at $12.61 and $12.72 respectively - a relatively tight $0.11 spread nationwide.
How many providers perform Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg?
Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg is comparatively uncommon: only 211 providers nationally billed Medicare for it in 2023, serving 230 beneficiaries via 219.2K total services.
What is the billed-to-Medicare markup for Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg?
Providers bill 3.5x what Medicare pays for Injection, Paclitaxel Protein-Bound Particles (american Regent) Not Therapeutically Equivalent To J9264, 1 Mg - one of the smaller markups in the catalog at 253% above the Medicare rate.
Related Guides
Tips to reduce out-of-pocket costs
Your right to upfront pricing
How Medicare payments work
Decode charges and codes
Why bills exceed actual costs
Geographic pricing factors
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainProcedure is rendered directly from CMS Medicare Physician & Other Practitioners data, no number is typed in by an editor. This page draws directly on CMS Medicare Physician & Other Practitioners data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.